CN114808179B - Composite material with controllable relaxation time and preparation method and application thereof - Google Patents
Composite material with controllable relaxation time and preparation method and application thereof Download PDFInfo
- Publication number
- CN114808179B CN114808179B CN202210324742.4A CN202210324742A CN114808179B CN 114808179 B CN114808179 B CN 114808179B CN 202210324742 A CN202210324742 A CN 202210324742A CN 114808179 B CN114808179 B CN 114808179B
- Authority
- CN
- China
- Prior art keywords
- relaxation time
- acid
- chain fatty
- long
- composite material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000002872 contrast media Substances 0.000 claims abstract description 23
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 23
- 239000001257 hydrogen Substances 0.000 claims abstract description 23
- 239000002861 polymer material Substances 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000001523 electrospinning Methods 0.000 claims abstract description 6
- 239000000835 fiber Substances 0.000 claims description 43
- -1 ester compound Chemical class 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 29
- 229920000642 polymer Polymers 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 16
- 229920001400 block copolymer Polymers 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000009987 spinning Methods 0.000 claims description 15
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 10
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 8
- 150000002194 fatty esters Chemical class 0.000 claims description 8
- 229920000573 polyethylene Polymers 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 6
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 6
- 239000004626 polylactic acid Substances 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical group 0.000 claims description 5
- 229920000728 polyester Polymers 0.000 claims description 5
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004952 Polyamide Substances 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- 229920001577 copolymer Polymers 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims description 4
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 4
- 229920002647 polyamide Polymers 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 239000004632 polycaprolactone Substances 0.000 claims description 4
- 229920000098 polyolefin Polymers 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 229920002301 cellulose acetate Polymers 0.000 claims description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 235000010981 methylcellulose Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 2
- KXJGSNRAQWDDJT-UHFFFAOYSA-N 1-acetyl-5-bromo-2h-indol-3-one Chemical compound BrC1=CC=C2N(C(=O)C)CC(=O)C2=C1 KXJGSNRAQWDDJT-UHFFFAOYSA-N 0.000 claims description 2
- ROGIWVXWXZRRMZ-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1 ROGIWVXWXZRRMZ-UHFFFAOYSA-N 0.000 claims description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims description 2
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 108010073385 Fibrin Proteins 0.000 claims description 2
- 102000009123 Fibrin Human genes 0.000 claims description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 2
- 108010022355 Fibroins Proteins 0.000 claims description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 229920002292 Nylon 6 Polymers 0.000 claims description 2
- 229920000305 Nylon 6,10 Polymers 0.000 claims description 2
- 229920002302 Nylon 6,6 Polymers 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 2
- 239000005062 Polybutadiene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 claims description 2
- 229930003836 cresol Natural products 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229950003499 fibrin Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 2
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 2
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 2
- 229920002857 polybutadiene Polymers 0.000 claims description 2
- 239000004417 polycarbonate Substances 0.000 claims description 2
- 229920000515 polycarbonate Polymers 0.000 claims description 2
- 239000004633 polyglycolic acid Substances 0.000 claims description 2
- 229920001195 polyisoprene Polymers 0.000 claims description 2
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 2
- 229920006324 polyoxymethylene Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 239000004800 polyvinyl chloride Substances 0.000 claims description 2
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229920006132 styrene block copolymer Polymers 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 1
- 238000010041 electrostatic spinning Methods 0.000 claims 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 229920001707 polybutylene terephthalate Polymers 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 19
- 239000011148 porous material Substances 0.000 abstract description 11
- 238000005516 engineering process Methods 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 239000002616 MRI contrast agent Substances 0.000 abstract description 2
- 239000002657 fibrous material Substances 0.000 abstract description 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 231100000956 nontoxicity Toxicity 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 72
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 34
- 238000002595 magnetic resonance imaging Methods 0.000 description 26
- 239000005639 Lauric acid Substances 0.000 description 15
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 11
- 229920002961 polybutylene succinate Polymers 0.000 description 9
- 239000004631 polybutylene succinate Substances 0.000 description 9
- 229960001701 chloroform Drugs 0.000 description 6
- 238000003384 imaging method Methods 0.000 description 6
- OAOABCKPVCUNKO-UHFFFAOYSA-N 8-methyl Nonanoic acid Chemical compound CC(C)CCCCCCC(O)=O OAOABCKPVCUNKO-UHFFFAOYSA-N 0.000 description 4
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 4
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-Lactic acid Natural products C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 4
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 229940022769 d- lactic acid Drugs 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- XAKXZZPEUKNHMA-UHFFFAOYSA-N decyl decanoate Chemical compound CCCCCCCCCCOC(=O)CCCCCCCCC XAKXZZPEUKNHMA-UHFFFAOYSA-N 0.000 description 2
- 238000002597 diffusion-weighted imaging Methods 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- YRHYCMZPEVDGFQ-UHFFFAOYSA-N methyl decanoate Chemical compound CCCCCCCCCC(=O)OC YRHYCMZPEVDGFQ-UHFFFAOYSA-N 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 2
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- NQDZCRSUOVPTII-UHFFFAOYSA-N 10-methylundecan-1-ol Chemical compound CC(C)CCCCCCCCCO NQDZCRSUOVPTII-UHFFFAOYSA-N 0.000 description 1
- QJRRBVNPIKYRQJ-UHFFFAOYSA-N 10-methylundecanoic acid Chemical compound CC(C)CCCCCCCCC(O)=O QJRRBVNPIKYRQJ-UHFFFAOYSA-N 0.000 description 1
- XUJLWPFSUCHPQL-UHFFFAOYSA-N 11-methyldodecan-1-ol Chemical compound CC(C)CCCCCCCCCCO XUJLWPFSUCHPQL-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 description 1
- BWDBEAQIHAEVLV-UHFFFAOYSA-N 6-methylheptan-1-ol Chemical compound CC(C)CCCCCO BWDBEAQIHAEVLV-UHFFFAOYSA-N 0.000 description 1
- QDTDKYHPHANITQ-UHFFFAOYSA-N 7-methyloctan-1-ol Chemical compound CC(C)CCCCCCO QDTDKYHPHANITQ-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- PLLBRTOLHQQAQQ-UHFFFAOYSA-N 8-methylnonan-1-ol Chemical compound CC(C)CCCCCCCO PLLBRTOLHQQAQQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- JTKHUJNVHQWSAY-UHFFFAOYSA-N 9-methyldecan-1-ol Chemical compound CC(C)CCCCCCCCO JTKHUJNVHQWSAY-UHFFFAOYSA-N 0.000 description 1
- BSJZHNLWBRBOOJ-UHFFFAOYSA-N C(OCCCCCCCCC)(OCCCCCCCCCCCC)=O Chemical compound C(OCCCCCCCCC)(OCCCCCCCCCCCC)=O BSJZHNLWBRBOOJ-UHFFFAOYSA-N 0.000 description 1
- CPKWSVHIZOMGPJ-UHFFFAOYSA-N C1(C2=CC=C(C(=O)OCCCCO1)C=C2)=O.C2(C1=CC=C(C(=O)OCCCCO2)C=C1)=O Chemical compound C1(C2=CC=C(C(=O)OCCCCO1)C=C2)=O.C2(C1=CC=C(C(=O)OCCCCO2)C=C1)=O CPKWSVHIZOMGPJ-UHFFFAOYSA-N 0.000 description 1
- DGPNTCACXCHFDI-UHFFFAOYSA-N Hexyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCC DGPNTCACXCHFDI-UHFFFAOYSA-N 0.000 description 1
- 101100330193 Homo sapiens CYREN gene Proteins 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 239000004440 Isodecyl alcohol Substances 0.000 description 1
- 239000004439 Isononyl alcohol Substances 0.000 description 1
- 238000012307 MRI technique Methods 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- BGYFCELTJPRWBA-UHFFFAOYSA-N Pentyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCC BGYFCELTJPRWBA-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- ZRNCNTSXSYXHOW-UHFFFAOYSA-N butyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCC ZRNCNTSXSYXHOW-UHFFFAOYSA-N 0.000 description 1
- IBELNUVGYVJQSE-UHFFFAOYSA-N butyl dodecyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCC IBELNUVGYVJQSE-UHFFFAOYSA-N 0.000 description 1
- IQDVZJZSGNXGAQ-UHFFFAOYSA-N carboxy propyl carbonate Chemical compound CCCOC(=O)OC(O)=O IQDVZJZSGNXGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- GBMGROVQZNYHAU-UHFFFAOYSA-N decanoic acid;ethyl decanoate Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(=O)OCC GBMGROVQZNYHAU-UHFFFAOYSA-N 0.000 description 1
- QMUOXVDESUNOIR-UHFFFAOYSA-N decyl dodecyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCCCCCCC QMUOXVDESUNOIR-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- GOAUNPQUDWQWCP-UHFFFAOYSA-N didodecyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCCCCCCCCC GOAUNPQUDWQWCP-UHFFFAOYSA-N 0.000 description 1
- GKVQWKKFAVIRMY-UHFFFAOYSA-N ditridecyl carbonate Chemical compound CCCCCCCCCCCCCOC(=O)OCCCCCCCCCCCCC GKVQWKKFAVIRMY-UHFFFAOYSA-N 0.000 description 1
- CNHLKAHXHBXEHS-UHFFFAOYSA-N diundecyl carbonate Chemical compound CCCCCCCCCCCOC(=O)OCCCCCCCCCCC CNHLKAHXHBXEHS-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- QIKAHSRIZZRLNA-UHFFFAOYSA-N dodecyl heptyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCCCC QIKAHSRIZZRLNA-UHFFFAOYSA-N 0.000 description 1
- QOHLLPCKATXISR-UHFFFAOYSA-N dodecyl hexyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCCC QOHLLPCKATXISR-UHFFFAOYSA-N 0.000 description 1
- LIPIURJJRUOGSS-UHFFFAOYSA-N dodecyl hydrogen carbonate Chemical compound CCCCCCCCCCCCOC(O)=O LIPIURJJRUOGSS-UHFFFAOYSA-N 0.000 description 1
- CTPHVAHFFHJRGA-UHFFFAOYSA-N dodecyl octyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCCCCC CTPHVAHFFHJRGA-UHFFFAOYSA-N 0.000 description 1
- IJMLRYXUSOYNQM-UHFFFAOYSA-N dodecyl pentyl carbonate Chemical compound CCCCCCCCCCCCOC(=O)OCCCCC IJMLRYXUSOYNQM-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- MPLLSYWBBPPERF-UHFFFAOYSA-N heptyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCC MPLLSYWBBPPERF-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- JZHKSJXMXQZMCR-UHFFFAOYSA-N nonyl decanoate Chemical compound CCCCCCCCCOC(=O)CCCCCCCCC JZHKSJXMXQZMCR-UHFFFAOYSA-N 0.000 description 1
- WWDHABCVIVMHKP-UHFFFAOYSA-N nonyl nonanoate Chemical compound CCCCCCCCCOC(=O)CCCCCCCC WWDHABCVIVMHKP-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HRPZGPXWSVHWPB-UHFFFAOYSA-N octyl decanoate Chemical compound CCCCCCCCCC(=O)OCCCCCCCC HRPZGPXWSVHWPB-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920005594 polymer fiber Polymers 0.000 description 1
- OVFMRFMJVFDSAA-UHFFFAOYSA-N propyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC OVFMRFMJVFDSAA-UHFFFAOYSA-N 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- VOCBWIIFXDYGNZ-IXKNJLPQSA-N testosterone enanthate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC2 VOCBWIIFXDYGNZ-IXKNJLPQSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/88—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds
- D01F6/92—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polycondensation products as major constituent with other polymers or low-molecular-weight compounds of polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/12—Macromolecular compounds
- A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
- D01D5/0092—Electro-spinning characterised by the electro-spinning apparatus characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F2/00—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
- D01F2/06—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from viscose
- D01F2/08—Composition of the spinning solution or the bath
- D01F2/10—Addition to the spinning solution or spinning bath of substances which exert their effect equally well in either
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F2/00—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof
- D01F2/24—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives
- D01F2/28—Monocomponent artificial filaments or the like of cellulose or cellulose derivatives; Manufacture thereof from cellulose derivatives from organic cellulose esters or ethers, e.g. cellulose acetate
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
- D01F6/50—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polyalcohols, polyacetals or polyketals
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F6/00—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof
- D01F6/44—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds
- D01F6/56—Monocomponent artificial filaments or the like of synthetic polymers; Manufacture thereof from mixtures of polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds as major constituent with other polymers or low-molecular-weight compounds of polymers of cyclic compounds with one carbon-to-carbon double bond in the side chain
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
- Y02P70/62—Manufacturing or production processes characterised by the final manufactured product related technologies for production or treatment of textile or flexible materials or products thereof, including footwear
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Artificial Filaments (AREA)
Abstract
本发明属于功能纤维材料领域,公开了一种可控弛豫时间的复合材料及其制备方法和应用。通过静电纺丝技术将有机含氢分子造影剂负载在高分子材料的孔洞中,使得有机含氢分子造影剂受限,从而引起其氢原子弛豫时间的降低。在不添加额外物质的情况下,仅改变负载高分子材料的结构即可实现对有机含氢分子造影剂弛豫时间的调控。相较于已公开技术具有生物安全性高、无毒、无过敏、适用范围广的特点。可以引用于高分子MRI造影剂、标准弛豫时间样品、标准MRI信号强度的材料的制备。
The invention belongs to the field of functional fiber materials, and discloses a composite material with controllable relaxation time, a preparation method and application thereof. The organic hydrogen-containing molecular contrast agent is loaded in the pores of the polymer material by electrospinning technology, so that the organic hydrogen-containing molecular contrast agent is confined, thereby reducing the relaxation time of its hydrogen atoms. Without adding additional substances, the relaxation time of the organic hydrogen-containing molecular contrast agent can be adjusted only by changing the structure of the loaded polymer material. Compared with the disclosed technology, it has the characteristics of high biological safety, non-toxicity, non-allergy and wide application range. It can be used in the preparation of polymeric MRI contrast agents, standard relaxation time samples, and standard MRI signal intensity materials.
Description
技术领域technical field
本发明属于功能纤维材料领域,更具体地,涉及一种可控弛豫时间的复合材料及其制备方法与应用。The invention belongs to the field of functional fiber materials, and more specifically relates to a composite material with controllable relaxation time and its preparation method and application.
背景技术Background technique
磁共振成像技术(MRI)Magnetic Resonance Imaging (MRI)
磁共振是指原子核在一定条件下与外加磁场共振的物理现象。磁共振成像技术(MRI)的基本工作原理是将被测物体置于特殊的磁场中,用无线电射频脉冲激发物体内的氢原子核,引起氢原子核共振,并吸收能量。在停止射频脉冲后,氢原子核将吸收的能量释放出来,按特定频率发出无线电信号。这一无线电信号被MRI设备的接收器收集,经计算机处理获得图像。目前人用MRI设备所采集的信号主要都自于氢原子(见杨正汉等人著《磁共振成像技术指南》,人民军医出版社,2010:P18-19)。Magnetic resonance refers to the physical phenomenon that atomic nuclei resonate with an external magnetic field under certain conditions. The basic working principle of magnetic resonance imaging (MRI) is to place the measured object in a special magnetic field, and use radio frequency pulses to excite the hydrogen nuclei in the object, causing the hydrogen nuclei to resonate and absorb energy. After stopping the radio frequency pulses, the hydrogen nuclei release the absorbed energy, emitting a radio signal at a specific frequency. This radio signal is picked up by a receiver in the MRI machine and processed by a computer to create an image. At present, the signals collected by human MRI equipment are mainly from hydrogen atoms (see Yang Zhenghan et al. "Magnetic Resonance Imaging Technology Guide", People's Military Medical Press, 2010: P18-19).
MRI的信号强度与弛豫时间MRI signal intensity and relaxation time
不同环境下的氢原子(如被键合、处于孔道中、高温等),在被射频脉冲激发后,回归基态时释放能量的速度有快有慢。这个能量释放过程被称为弛豫,弛豫存在两个独立的过程,被称为T1与T2弛豫(或横向、纵向弛豫),两个弛豫过程发生的所需要消耗的时间被称为T1与T2弛豫时间。Hydrogen atoms in different environments (such as being bonded, in pores, high temperature, etc.), after being excited by radio frequency pulses, release energy at different speeds when returning to the ground state. This energy release process is called relaxation. There are two independent processes of relaxation, which are called T1 and T2 relaxation (or transverse and longitudinal relaxation). The time required for the two relaxation processes to occur is called are T1 and T2 relaxation times.
MRI有多种扫描序列用于获得信号,其中最常用的序列有T1WI(T1加权成像)、T2WI(T2加权成像)、PDWI(质子加权成像)、DWI(扩散加权成像)等,而以上这些常用扫描序列所得到的图像的信号强度均受到氢原子T1与T2弛豫时间的影响,也就是说不同弛豫时间的氢原子在MRI图像上的信号强度是不同的(见Ray H.Hashemi et al.MRI:TheBasics.Lippincott Williams&Wilkins,2012,p54-55)。MRI has a variety of scanning sequences used to obtain signals, the most commonly used sequences are T1WI (T1-weighted imaging), T2WI (T2-weighted imaging), PDWI (proton-weighted imaging), DWI (diffusion-weighted imaging), etc., and these commonly used The signal intensity of the image obtained by the scanning sequence is affected by the relaxation time of hydrogen atoms T1 and T2, that is to say, the signal intensity of hydrogen atoms with different relaxation times on the MRI image is different (see Ray H.Hashemi et al . MRI: The Basics. Lippincott Williams & Wilkins, 2012, p54-55).
高分子材料无法产生足够的MRI信号Polymer materials cannot generate sufficient MRI signal
高分子材料已被广泛用于制造医疗器械,然而高分子材料所含有的氢原子,其T2弛豫时间过短,在数十毫秒甚至数十纳秒的范围内。MRI由于本身设备的限制难以探测如此短弛豫时间的氢原子,从而使得高分子在人体内无法被MRI成像。这一现象在Yuan等人的研究(Yuan D C et al.Journal of Biomedical Materials Research Part B-AppliedBiomaterials,2019,107(7):2305-2316)中就可以看到,他们将聚合物(聚丁二酸丁二酯-对苯二甲酸丁二酯)纤维作为人造椎间盘替代髓核,但其在MRI下完全无信号。这一问题导致医生难以通过MRI获知植入的高分子材料在患者体内的信息,对治疗带来障碍。Polymer materials have been widely used in the manufacture of medical devices, but the T2 relaxation time of hydrogen atoms contained in polymer materials is too short, in the range of tens of milliseconds or even tens of nanoseconds. MRI is difficult to detect hydrogen atoms with such a short relaxation time due to the limitations of its own equipment, so that polymers in the human body cannot be imaged by MRI. This phenomenon can be seen in the research of Yuan et al. (Yuan D C et al. Journal of Biomedical Materials Research Part B-Applied Biomaterials, 2019, 107(7): 2305-2316). Butylene terephthalate-butylene terephthalate) fibers were used as artificial discs to replace the nucleus pulposus, but they were completely signalless under MRI. This problem makes it difficult for doctors to obtain the information of implanted polymer materials in the patient's body through MRI, which brings obstacles to treatment.
已公开造影技术及其缺陷Published imaging techniques and their drawbacks
MRI造影技术种类多样,其中一种常用的方法是使用造影剂。MRI造影剂按照提供信号的分子类型,可以分类两大类:(1)水分子,通过具有磁性的造影剂缩短水分子的T1与T2弛豫时间,从而改变MRI信号强度。使得造影剂所在位置的水分子信号强度发生显著变化,从而为该位置提供足够的信号对比度。这一类型的造影剂最为常见;(2)油脂、植物油、蔗糖聚酯等有机含氢分子(见杨正汉等人著《磁共振成像技术指南》,人民军医出版社,2010:P390),这些分子具有一个统一的特点,它们的分子组成中总是有长链脂肪基团,这是因为长链脂肪中的氢是其MRI信号的来源。这类分子中的氢天然就可以作为高MRI信号强度的来源。There are many types of MRI contrast techniques, one of which is the use of contrast agents. MRI contrast agents can be classified into two categories according to the type of molecules that provide signals: (1) Water molecules, which shorten the T1 and T2 relaxation times of water molecules through magnetic contrast agents, thereby changing the MRI signal intensity. The signal intensity of the water molecules at the position where the contrast agent is located changes significantly, thereby providing sufficient signal contrast for the position. This type of contrast agent is the most common; (2) organic hydrogen-containing molecules such as fats, vegetable oils, and sucrose polyesters (see "Guidelines for Magnetic Resonance Imaging Techniques" by Yang Zhenghan et al., People's Military Medical Press, 2010: P390), these molecules They have a unified feature that they always have long-chain fatty groups in their molecular composition, because the hydrogen in long-chain fat is the source of their MRI signals. The hydrogen in these molecules is a natural source of high MRI signal intensity.
对于第(2)类有机含氢分子造影剂而言,由于弛豫时间是物质本身的性质,有机含氢分子在仅自身存在的情况下,其弛豫时间(即MRI信号强度)是不可调的,仅能表现为单一数值。然而对于应用在不同人体部位的高分子植入医疗器械,其需要造影的MRI信号强度是不同的,仅能表现为单一信号强度的有机含氢分子造影剂,在面对MRI信号强度随使用环境需要变化的情况时,有机含氢分子的性能就不足以满足可变信号强度的需求了。For the (2) class of organic hydrogen-containing molecular contrast agents, since the relaxation time is the property of the substance itself, the relaxation time (ie, the MRI signal intensity) of the organic hydrogen-containing molecule is not adjustable when it only exists by itself. , can only be expressed as a single value. However, for polymer implanted medical devices used in different parts of the human body, the MRI signal intensity required for imaging is different, and the organic hydrogen-containing molecular contrast agent that can only be expressed as a single signal intensity, in the face of the MRI signal intensity varies with the use environment. When varying conditions are required, the performance of organic hydrogen-containing molecules is not sufficient for variable signal strength.
发明内容Contents of the invention
针对已公开技术存在的缺陷,本发明的目的是:(1)提供一种可控弛豫时间的复合材料的制备方法;(2)提供该种复合材料的应用;以实现对负载在高分子材料中有机含氢分子造影剂弛豫时间的控制,进而满足高分子材料的MRI造影需求。For the defects of the disclosed technology, the purpose of the present invention is to: (1) provide a preparation method of a composite material with controllable relaxation time; (2) provide the application of this kind of composite material; The control of the relaxation time of the organic hydrogen-containing molecular contrast agent in the material can meet the MRI contrast requirements of polymer materials.
本发明控制有机含氢分子弛豫时间的方法与原理如下:The method and principle of the present invention to control the relaxation time of organic hydrogen-containing molecules are as follows:
物质的弛豫时间主要是由其分子结构和物质状态(如固、液、气)决定的。但分子所处的环境也会影响其弛豫时间,例如,处在不同孔隙尺寸中的水分子,由于受限于孔道壁,弛豫时间会发生变化,因此可以利用水分子的弛豫时间来测量孔道尺寸。那么类似的,也可以通过构建具有孔道结构的高分子基体,对受限于高分子孔道内部的有机含氢分子造影剂的弛豫时间进行控制。有机含氢分子造影剂中含有大量氢原子,当它们受限在高分子形成的孔道中时,分子在运动中会与高分子孔道壁发生碰撞,使得氢原子的弛豫时间变短,进而改变其MRI信号。The relaxation time of a substance is mainly determined by its molecular structure and state of matter (such as solid, liquid, gas). However, the environment of the molecule will also affect its relaxation time. For example, the relaxation time of water molecules in different pore sizes will change due to being limited by the pore wall. Therefore, the relaxation time of water molecules can be used to determine Measure the hole size. Similarly, by constructing a polymer matrix with a pore structure, the relaxation time of the organic hydrogen-containing molecular contrast agent confined inside the polymer pore can be controlled. Organic hydrogen-containing molecular contrast agents contain a large number of hydrogen atoms. When they are confined in the pores formed by polymers, the molecules will collide with the walls of the polymer pores during motion, shortening the relaxation time of the hydrogen atoms, thereby changing the Its MRI signal.
本发明目的通过以下具体技术方案实现:The object of the invention is achieved through the following specific technical solutions:
一种可控弛豫时间的复合材料的制备方法,包括如下步骤:A method for preparing a composite material with controllable relaxation time, comprising the steps of:
(S1)配制纺丝溶液:将高分子材料溶解在溶剂中形成高分子溶液,将有机含氢分子造影剂溶解在溶剂中形成造影剂溶液;(S1) preparing spinning solution: dissolving the polymer material in a solvent to form a polymer solution, and dissolving an organic hydrogen-containing molecular contrast agent in a solvent to form a contrast agent solution;
(S2)将两种溶液混合进行静电纺丝;(S2) mixing the two solutions for electrospinning;
(S3)将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气,得到可控弛豫时间的复合材料。(S3) drying the collected composite fiber product, immersing it in water, exhausting the air in the fiber, and obtaining a composite material with a controllable relaxation time.
步骤(S1)中所述的高分子材料为聚酯类高分子及其衍生物、聚烯烃类高分子及其衍生物、聚酰胺类高分子及其衍生物、淀粉及其衍生物、纤维素及其衍生物、壳聚糖、聚甲醛、透明质酸、纤维蛋白、丝素蛋白,以上聚合物的共混共聚物与嵌段共聚物中的一种或两种以上的混合。The polymer material described in step (S1) is polyester polymer and its derivatives, polyolefin polymer and its derivatives, polyamide polymer and its derivatives, starch and its derivatives, cellulose And its derivatives, chitosan, polyoxymethylene, hyaluronic acid, fibrin, silk fibroin, one or more than two kinds of blended copolymers and block copolymers of the above polymers are mixed.
优选地,聚酯类高分子及其衍生物为聚乙交酯、聚乳酸、聚己内酯、聚羟基乙酸、聚甲基丙烯酸甲酯、聚对苯二甲酸乙二酯、聚对苯二甲酸丁二酯、聚碳酸酯中的至少一种;聚烯烃类高分子及其衍生物为聚乙烯、聚丙烯、聚氯乙烯、聚四氟乙烯、聚异戊二烯、聚乙烯基吡咯烷酮、聚乙烯醇、聚丙烯腈中的至少一种;聚酰胺类高分子及其衍生物为尼龙6、尼龙66、尼龙610、尼龙1212中的至少一种;淀粉及其衍生物为羟乙基淀粉和/或羧甲基淀粉;纤维素及其衍生物为醋酸纤维素、甲基纤维素、乙基纤维素、羟乙基纤维素、氰乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素中的至少一种;共混共聚物与嵌段共聚物为左旋-右旋聚乳酸共聚物、聚乙二醇-聚乳酸嵌段共聚物、聚乙二醇-聚己内酯嵌段共聚物、聚乙二醇-聚乙烯吡咯烷酮嵌段共聚物、聚苯乙烯-聚丁二烯嵌段共聚物、苯乙烯-丁二烯-苯乙烯三嵌段共聚物、聚苯乙烯-聚(乙烯-丁烯)-聚苯乙烯嵌段共聚物、苯乙烯-异戊二烯/丁二烯-苯乙烯嵌段共聚物、聚苯乙烯-聚丁二烯-聚苯乙烯嵌段共聚物中的至少一种。Preferably, the polyester polymer and its derivatives are polyglycolide, polylactic acid, polycaprolactone, polyglycolic acid, polymethyl methacrylate, polyethylene terephthalate, polyethylene terephthalate At least one of butylene formate and polycarbonate; polyolefin polymers and their derivatives are polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, polyisoprene, polyvinylpyrrolidone, At least one of polyvinyl alcohol and polyacrylonitrile; polyamide polymer and its derivatives are at least one of nylon 6, nylon 66, nylon 610, and nylon 1212; starch and its derivatives are hydroxyethyl starch and/or carboxymethyl starch; cellulose and its derivatives are cellulose acetate, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, cyanoethyl cellulose, hydroxypropyl cellulose, hydroxypropyl At least one of methyl cellulose; blended copolymers and block copolymers are L-D-polylactic acid copolymers, polyethylene glycol-polylactic acid block copolymers, polyethylene glycol-polycaprolactone Block copolymer, polyethylene glycol-polyvinylpyrrolidone block copolymer, polystyrene-polybutadiene block copolymer, styrene-butadiene-styrene triblock copolymer, polystyrene- Poly(ethylene-butylene)-polystyrene block copolymer, styrene-isoprene/butadiene-styrene block copolymer, polystyrene-polybutadiene-polystyrene block copolymer at least one of the
步骤(S1)中所述的有机含氢分子造影剂为长链脂肪一元酸、长链脂肪一元醇、一元酸一元醇长链脂肪酯、一元酸多元醇长链脂肪酯中的一种或两种以上的混合。The organic hydrogen-containing molecular contrast agent described in the step (S1) is one or both of long-chain fatty monobasic acid, long-chain fatty monohydric alcohol, monobasic acid monohydric alcohol long-chain fatty ester, and monobasic acid polyhydric alcohol long-chain fatty ester. A mixture of the above.
优选地,长链脂肪一元酸为含碳数在8~24的脂肪一元酸;长链脂肪一元醇为含碳数在8~16的脂肪一元醇;一元酸一元醇长链脂肪酯为由长链脂肪一元酸与长链脂肪一元醇形成的含碳数在8~28的酯;一元酸多元醇长链脂肪酯为由丙三醇、蔗糖、葡萄糖、果糖与含碳数在8~18的长链脂肪一元酸形成的酯化合物。Preferably, the long-chain fatty monobasic acid is a fatty monobasic acid with a carbon number of 8 to 24; the long-chain fatty monohydric alcohol is a fatty monohydric alcohol with a carbon number of 8 to 16; The ester of chain fatty monobasic acid and long-chain fatty monohydric alcohol with 8 to 28 carbons; the monobasic acid polyalcohol long-chain fatty ester is composed of glycerol, sucrose, glucose, fructose and the ester with 8 to 18 carbons Esters of long-chain fatty monobasic acids.
更优选地,含碳数在8~24的脂肪一元酸为正辛酸、正壬酸、正癸酸、正十一碳酸、正十二碳酸、异辛酸、异壬酸、异癸酸、异十一碳酸、异十二碳酸、肉豆蔻酸、棕榈酸、硬脂酸、油酸、异油酸、顺芥子酸、神经酸中的至少一种;含碳数在8~16的脂肪一元醇为正辛醇、正壬醇、正癸醇、正十一醇、正十二醇、正十三醇、正十四醇、正十五醇、正十六醇、异辛醇、异壬醇、异癸醇、异十一醇、异十二醇、异十三醇、异十四醇、异十五醇中的至少一种;含碳数在8~28的一元酸一元醇长链脂肪酯为辛酸辛酯、壬酸壬酯、癸酸癸酯、十一碳酸十一酯、十二碳酸十二酯、十三碳酸十三酯、十四碳酸十四酯、癸酸甲酯、癸酸乙酯、癸酸丙酯、癸酸丁酯、癸酸戊酯、癸酸己酯、癸酸庚酯、癸酸辛酯、癸酸壬酯、十二碳酸甲酯、十二碳酸乙酯、十二碳酸丙酯、十二碳酸丁酯、十二碳酸戊酯、十二碳酸己酯、十二碳酸庚酯、十二碳酸辛酯、十二碳酸壬酯、十二碳酸癸酯、十二碳酸十一酯中的至少一种。由丙三醇、蔗糖、葡萄糖、果糖与含碳数在8~18的长链脂肪一元酸形成的酯化合物为单/双/三辛酸甘油酯、单/双/三癸酸甘油酯、单/双/三月桂酸甘油酯、单/双/三硬脂酸甘油酯、单/双/三棕榈酸甘油酯、蔗糖/葡萄糖/果糖癸酸酯、蔗糖/葡萄糖/果糖月桂酸酯、蔗糖/葡萄糖/果糖硬脂酸酯中的至少一种。More preferably, the fatty monobasic acid containing 8 to 24 carbons is n-octanoic acid, n-nonanoic acid, n-decanoic acid, n-undecanoic acid, n-dodecanoic acid, isooctanoic acid, isononanoic acid, isodecanoic acid, isodecanoic acid At least one of monocarbonic acid, isododecanoic acid, myristic acid, palmitic acid, stearic acid, oleic acid, vaccinic acid, cisapinic acid, and nervonic acid; fatty monohydric alcohols containing 8 to 16 carbons are n-octanol, n-nonanol, n-decyl alcohol, n-undecyl alcohol, n-dodecyl alcohol, n-tridecyl alcohol, n-tetradecyl alcohol, n-pentadecanol, n-hexadecanol, isooctyl alcohol, isononyl alcohol, At least one of isodecyl alcohol, isoundecanol, isododecanol, isotridecanol, isotetradecyl alcohol, and isopentadecyl alcohol; monobasic acid monoalcohol long-chain fatty esters containing 8 to 28 carbons Octyl octanoate, nonyl nonanoate, decyl caprate, undecyl undecyl carbonate, dodecyl dodecyl carbonate, tridecyl tridecyl carbonate, tetradecyl tetradecanoate, methyl caprate, capric acid Ethyl caprate, propyl caprate, butyl caprate, pentyl caprate, hexyl caprate, heptyl caprate, octyl caprate, nonyl caprate, methyl dodecanoate, ethyl dodecanoate, Propyl Dicarbonate, Butyl Dodecyl Carbonate, Pentyl Dodecyl Carbonate, Hexyl Dodecyl Carbonate, Heptyl Dodecyl Carbonate, Octyl Dodecyl Carbonate, Nonyl Dodecyl Carbonate, Decyl Dodecyl Carbonate, Dodecyl Carbonate At least one of undecyl esters. The ester compounds formed by glycerol, sucrose, glucose, fructose and long-chain fatty monobasic acids with carbon numbers from 8 to 18 are mono/di/tricaprylic glycerides, mono/di/tricapric glycerides, mono/dicaprylic acid glycerides, Glyceryl Di/Trilaurate, Glyceryl Mono/Dis/Tripostearate, Glyceryl Mono/Di/Tripalmitate, Sucrose/Glucose/Fructose Caprate, Sucrose/Glucose/Fructose Laurate, Sucrose/Glucose /at least one of fructose stearate.
步骤(S1)中所述的溶剂为溶剂戊烷、正己烷、甲基环己烷、二氯甲烷、三氯甲烷、二氯乙烷、四氯乙烷、四氯化碳、丙烯酸甲酯、四氢呋喃、甲基四氢呋喃、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、二甲基亚砜、乙醚、石油醚、丙酮、甲酸、乙酸、三氟乙酸、六氟异丙醇、二甲苯、甲苯、苯酚、氯苯、硝基苯、甲酚、苯甲醚、甲醇、乙醇、1-丙醇、2-丙醇、1-丁醇、2-丁醇、戊醇中的一种或两种以上的混合。The solvent described in step (S1) is solvent pentane, n-hexane, methylcyclohexane, methylene dichloride, chloroform, ethylene dichloride, tetrachloroethane, carbon tetrachloride, methyl acrylate, Tetrahydrofuran, methyl tetrahydrofuran, N,N-dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, diethyl ether, petroleum ether, acetone, formic acid, acetic acid, trifluoroacetic acid, hexafluoroiso Propanol, xylene, toluene, phenol, chlorobenzene, nitrobenzene, cresol, anisole, methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, pentanol one or a mixture of two or more.
步骤(S1)中所述的高分子溶液的浓度为5~45wt%,造影剂溶液浓度为20~90wt%。The concentration of the polymer solution in step (S1) is 5-45 wt%, and the concentration of the contrast agent solution is 20-90 wt%.
步骤(S2)中所述静电纺丝条件为:供液装置供液速率0.1~10mL/h,喷丝头与收集装置间距离5~50cm,喷丝头处接高压10~50kV,收集装置处接高压0~-50kV。The electrospinning conditions described in step (S2) are: the liquid supply rate of the liquid supply device is 0.1-10mL/h, the distance between the spinneret and the collection device is 5-50cm, the spinneret is connected to a high voltage of 10-50kV, and the collection device is connected to a high voltage of 10-50kV. Connect to
步骤(S3)中所述的排尽纤维内空气的原因在于,空气与高分子复合纤维的磁导率有显著差别,会影响磁场的不均性,导致MRI成像效果变差,因此不能有空气残留。The reason for exhausting the air in the fiber described in step (S3) is that the magnetic permeability of the air and the polymer composite fiber is significantly different, which will affect the inhomogeneity of the magnetic field and cause the MRI imaging effect to deteriorate, so there cannot be air residual.
步骤(S3)中所述的最终复合纤维产物,有机含氢分子造影剂在复合纤维中的弛豫时间可以最多降低至其本体的10%,且连续变化。In the final composite fiber product described in step (S3), the relaxation time of the organic hydrogen-containing molecular contrast agent in the composite fiber can be reduced to 10% of its bulk at most, and can be changed continuously.
一种复合纤维通过上述方法制备得到。通过以上工艺制备得到的复合纤维可以应用于:(1)为高分子材料提供MRI信号;(2)提供具有标准弛豫时间的样品,用于设备校准;(3)作为具有标准MRI信号强度的植入材料,用于人体内MRI信号标定。A composite fiber is prepared by the above method. The composite fibers prepared by the above process can be applied to: (1) provide MRI signals for polymer materials; (2) provide samples with standard relaxation times for equipment calibration; (3) serve as samples with standard MRI signal strengths The implant material is used for MRI signal calibration in the human body.
本发明的制备方法及所得产物相较于已公开技术具有如下优点及有益效果:Compared with the disclosed technology, the preparation method and the resulting product of the present invention have the following advantages and beneficial effects:
(1)已公开技术均使用含金属的造影剂(螯合物、纳米粒子等)来改变氢原子的弛豫时间,但这些物质都具有一定的毒性或致敏性,本发明方法仅通过改变高分子的结构即可调控氢原子的弛豫时间,未引入其它物质,有更高的安全性;(1) The disclosed technologies all use metal-containing contrast agents (chelates, nanoparticles, etc.) to change the relaxation time of hydrogen atoms, but these substances have certain toxicity or sensitization, and the method of the present invention only changes The structure of the polymer can regulate the relaxation time of the hydrogen atom, and no other substances are introduced, which has higher safety;
(2)本发明方法采用的静电纺丝设备简单,制备具有特定孔洞结构的高分子纤维不影响纤维的完整形貌。因此,本发明的方法不会限制高分子材料原本的应用方向;(2) The electrospinning equipment adopted in the method of the present invention is simple, and the preparation of the polymer fiber with a specific pore structure does not affect the complete shape of the fiber. Therefore, the method of the present invention will not limit the original application direction of polymer materials;
(3)本发明控制弛豫时间的方法适用范围广,可调控的有机含氢分子造影剂种类多,可用于调控含长脂肪链分子中的氢原子的弛豫时间。(3) The method for controlling the relaxation time of the present invention has a wide range of applications, and there are many types of adjustable organic hydrogen-containing molecular contrast agents, which can be used to regulate the relaxation time of hydrogen atoms in molecules containing long aliphatic chains.
附图说明Description of drawings
图1.复合纤维的高分子孔洞结构;Figure 1. The polymer pore structure of the composite fiber;
图2.静电纺丝装置示意图;Figure 2. Schematic diagram of the electrospinning device;
图3.实施例1-4产物、聚丁二酸丁二醇酯与月桂酸的低场核磁共振谱仪测试结果;Fig. 3. the low-field nuclear magnetic resonance spectrometer test result of embodiment 1-4 product, polybutylene succinate and lauric acid;
图4.实施例1-4产物中负载的月桂酸相较于月桂酸本体的相对结晶度;Fig. 4. the relative crystallinity of the lauric acid loaded in the embodiment 1-4 product compared to the lauric acid bulk;
图5.实施例5-8产物、聚对苯二甲酸乙二醇酯与癸酸的低场核磁共振谱仪测试结果。Fig. 5. the low-field nuclear magnetic resonance spectrometer test result of embodiment 5-8 product, polyethylene terephthalate and capric acid.
具体实施方式Detailed ways
下面结合实施例及附图对本发明作进一步详细的描述,但本发明的实施方式不限于此。The present invention will be further described in detail below in conjunction with the embodiments and the accompanying drawings, but the embodiments of the present invention are not limited thereto.
实施例1Example 1
将聚丁二酸丁二醇酯溶解在三氯甲烷中,形成质量分数为60%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为75%的B溶液,将A、B两种溶液以1:2的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in chloroform to form a solution A with a mass fraction of 60%, and lauric acid (dodecanoic acid) is dissolved in chloroform to form a solution B with a mass fraction of 75%. , Mix the two solutions of A and B at a mass ratio of 1:2 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例2Example 2
将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为80%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form a mass fraction of 40% A solution, and lauric acid (dodecanoic acid) is dissolved in trichloromethane to form a mass fraction of 80% B solution, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例3Example 3
将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form the A solution that the mass fraction is 40%, and lauric acid (dodecanoic acid) is dissolved in the trichloromethane to form the B solution that the mass fraction is 60%, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例4Example 4
将聚丁二酸丁二醇酯溶解在三甲烷中,形成质量分数为40%的A溶液,将月桂酸(十二烷酸)溶解在三氯甲烷中形成质量分数为40%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polybutylene succinate is dissolved in trimethane to form a mass fraction of 40% A solution, and lauric acid (dodecanoic acid) is dissolved in trichloromethane to form a mass fraction of 40% B solution, Mix the two solutions of A and B at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率1mL/h,喷丝头与收集装置间距离20cm,喷丝头处接高压20kV,收集装置处接高压-2kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 1mL/h, the distance between the spinneret and the collection device was 20cm, the spinneret was connected to a high voltage of 20kV, and the collection device was connected to a high voltage of -2kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
为说明本发明方法与工艺的有效性,通过低场核磁共振谱仪测定实施例1-4产物的T2弛豫时间,结果如图3所示。通过图3可以得出以下结论:(a)聚丁二酸丁二醇酯的弛豫时间不在测试范围内,所有信息全部来自于月桂酸;(b)月桂酸中所含有的氢原子,表现出2个主要的弛豫时间,第一个在535ms处,第二个在283ms处;(c)月桂酸负载于聚丁二酸丁二醇酯纤维的孔洞中时,其所含氢原子弛豫时间的峰形不变,但在不同加工工艺下,弛豫时间连续可调。说明月桂酸负载于聚丁二酸丁二醇酯纤维中并不改变月桂酸所含氢原子的类型与相对数量,但会有效降低其所含氢原子的弛豫时间。In order to illustrate the effectiveness of the method and process of the present invention, the T2 relaxation time of the products of Examples 1-4 was measured by a low-field nuclear magnetic resonance spectrometer, and the results are shown in FIG. 3 . The following conclusions can be drawn by Fig. 3: (a) the relaxation time of polybutylene succinate is not within the test range, and all information comes from lauric acid; (b) the hydrogen atoms contained in lauric acid show There are two main relaxation times, the first one is at 535ms and the second one is at 283ms; (c) when lauric acid is loaded in the pores of polybutylene succinate fiber, the hydrogen atoms contained in it relax The peak shape of the relaxation time remains unchanged, but the relaxation time is continuously adjustable under different processing techniques. It shows that the loading of lauric acid in polybutylene succinate fiber does not change the type and relative quantity of hydrogen atoms contained in lauric acid, but it will effectively reduce the relaxation time of hydrogen atoms contained in it.
为说明月桂酸在聚丁二酸丁二醇酯中的受限情况,通过差式扫描量热仪测定实施例1-4产物复合纤维中的月桂酸对其本体的相对结晶度,结果如图4所示。从图4中可以看到,由于是相对于月桂酸本体的相对结晶度,因此月桂酸的数值为100%,而实施例1-4中的产物,其中负载的月桂酸相对结晶度均小于100%,且实施例4产物的下降幅度最大。在受限空间中材料的结晶难度增加,结晶度下降已经得到大量研究证实(见Lipeng Han etal.IOP Conference Series:Materials Science and Engineering,2017,182,012010)。从相对结晶度结果可知,实施例4在实施例1-4中,表现出的受限程度最高,对应地实施例4产物中的月桂酸,相较于月桂酸本体弛豫时间下降幅度也最大。In order to illustrate the limited situation of lauric acid in polybutylene succinate, the relative crystallinity of lauric acid in the composite fiber of the product of Example 1-4 is measured by differential scanning calorimeter to its body, and the results are as shown in Fig. 4. As can be seen from Fig. 4, owing to be relative to the relative crystallinity of lauric acid body, so the numerical value of lauric acid is 100%, and the product in embodiment 1-4, wherein the relative crystallinity of lauric acid of loading is all less than 100% %, and the range of decline of the product of Example 4 is the largest. The crystallization difficulty of materials in confined spaces increases, and the decrease in crystallinity has been confirmed by a large number of studies (see Lipeng Han et al. IOP Conference Series: Materials Science and Engineering, 2017, 182, 012010). From the results of relative crystallinity, it can be seen that Example 4 has the highest degree of restriction among Examples 1-4, and correspondingly, the relaxation time of lauric acid in the product of Example 4 has the largest decrease compared with the bulk relaxation time of lauric acid .
实施例5Example 5
将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为45%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为75%的B溶液,将A、B两种溶液以1:2的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 45%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form B solution with a mass fraction of 75%, and mix A and B solutions at a mass ratio of 1:2 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例6Example 6
将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为80%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form a solution B with a mass fraction of 80%, and mix the two solutions A and B at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例7Example 7
将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form a B solution with a mass fraction of 60%, and mix the two solutions A and B at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例8Example 8
将聚对苯二甲酸乙二醇酯溶解在二氯甲烷:三氟乙酸=2:1(质量比)的混合溶液中,形成质量分数为30%的A溶液,将癸酸(十烷酸)溶解在四氢呋喃中形成质量分数为40%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Polyethylene terephthalate is dissolved in the mixed solution of dichloromethane:trifluoroacetic acid=2:1 (mass ratio) to form A solution with a mass fraction of 30%, and decanoic acid (decanoic acid) Dissolve in tetrahydrofuran to form B solution with a mass fraction of 40%, and mix A and B solutions at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率0.5mL/h,喷丝头与收集装置间距离15cm,喷丝头处接高压16kV,收集装置处接高压-4kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 0.5mL/h, the distance between the spinneret and the collection device was 15cm, the spinneret was connected to a high voltage of 16kV, and the collection device was connected to a high voltage of -4kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
为说明本发明方法与工艺的普遍适用性,通过低场核磁共振谱仪测定实施例5-8产物的T2弛豫时间,测试结果如图5所示。从图5中可以得到以下结论:(a)聚对苯二甲酸乙二醇酯的弛豫时间不在测试范围内,所有信息全部来自于癸酸;癸酸中所含有的氢原子,表现出2个主要的弛豫时间,第一个在503ms处,第二个在243ms处;与图3结果类似地,负载在聚对苯二甲酸乙二醇酯纤维中的癸酸,其所含氢原子的弛豫时间有效减少了,可实现50ms至150ms的调整。实施例1-4(负载十二烷酸)与实施例5-8(负载十烷酸)的测试结果表明,本发明方法普遍适用于长链脂肪酸/醇/酯中氢原子弛豫时间的调控。In order to illustrate the universal applicability of the method and process of the present invention, the T2 relaxation time of the products of Examples 5-8 was measured by a low-field nuclear magnetic resonance spectrometer, and the test results are shown in FIG. 5 . From Fig. 5, following conclusions can be drawn: (a) the relaxation time of polyethylene terephthalate is not within the test range, and all information comes from capric acid; the hydrogen atom contained in capric acid shows 2 There are three main relaxation times, the first one is at 503ms, the second one is at 243ms; similar to the results in Fig. 3, the capric acid loaded in polyethylene terephthalate fibers contains hydrogen atoms The relaxation time is effectively reduced, which can be adjusted from 50ms to 150ms. The test results of Examples 1-4 (loaded dodecanoic acid) and Examples 5-8 (loaded decanoic acid) show that the method of the present invention is generally applicable to the regulation of hydrogen atom relaxation time in long-chain fatty acids/alcohols/esters .
实施例9Example 9
将聚乙烯醇溶解在水中,形成质量分数为5%的A溶液,将单硬脂酸甘油酯溶解在四氢呋喃中形成质量分数为60%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve polyvinyl alcohol in water to form a solution A with a mass fraction of 5%, and dissolve glyceryl monostearate in tetrahydrofuran to form a solution B with a mass fraction of 60%. The two solutions A and B are mixed at a ratio of 1:1 The mass ratio is mixed to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率0.1mL/h,喷丝头与收集装置间距离50cm,喷丝头处接高压50kV,收集装置处接高压-1kV。The solution is electrospun with the following parameters, the liquid supply device supply rate is 0.1mL/h, the distance between the spinneret and the collection device is 50cm, the spinneret is connected to a high voltage of 50kV, and the collection device is connected to a high voltage of -1kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例10Example 10
将苯乙烯-丁二烯-苯乙烯嵌段共聚物溶解在四氢呋喃中,形成质量分数为40%的A溶液,将正十五醇溶解在丙酮中形成质量分数为60%的B溶液,将A、B两种溶液以2:3的质量比混合得到纺丝溶液。Styrene-butadiene-styrene block copolymer is dissolved in tetrahydrofuran to form a solution A with a mass fraction of 40%, and n-pentadecanol is dissolved in acetone to form a solution B with a mass fraction of 60%. The two solutions of B and B are mixed at a mass ratio of 2:3 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压40kV,收集装置处接高压-20kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 40kV, and the collection device was connected to a high voltage of -20kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例11Example 11
将左旋/右旋乳酸无规共聚物溶解在二氯甲烷中,形成质量分数为24%的A溶液,将蔗糖癸酸酯溶解在N,N-二甲基乙酰胺中形成质量分数为90%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve L/D-lactic acid random copolymer in dichloromethane to form A solution with a mass fraction of 24%, and dissolve sucrose caprate in N,N-dimethylacetamide to form a mass fraction of 90% The B solution, the two solutions A and B are mixed at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压10kV,收集装置处接高压-50kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 10kV, and the collection device was connected to a high voltage of -50kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例12Example 12
将左旋/右旋乳酸无规共聚物溶解在二氯甲烷中,形成质量分数为24%的A溶液,将蔗糖癸酸酯溶解在N,N-二甲基乙酰胺中形成质量分数为50%的B溶液,将A、B两种溶液以1:1的质量比混合得到纺丝溶液。Dissolve L/D-lactic acid random copolymer in dichloromethane to form A solution with a mass fraction of 24%, and dissolve sucrose caprate in N,N-dimethylacetamide to form a mass fraction of 50% The B solution, the two solutions A and B are mixed at a mass ratio of 1:1 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率5mL/h,喷丝头与收集装置间距离30cm,喷丝头处接高压10kV,收集装置处接高压-50kV。The solution was electrospun with the following parameters, the liquid supply rate of the liquid supply device was 5mL/h, the distance between the spinneret and the collection device was 30cm, the spinneret was connected to a high voltage of 10kV, and the collection device was connected to a high voltage of -50kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
实施例13Example 13
将醋酸纤维素溶解在N,N-二甲基乙酰胺中,形成质量分数为10%的A溶液,将癸酸癸酯溶解在甲苯中形成质量分数为20%的B溶液,将A、B两种溶液以3:2的质量比混合得到纺丝溶液。Dissolve cellulose acetate in N,N-dimethylacetamide to form a solution A with a mass fraction of 10%, and dissolve decyl caprate in toluene to form a solution B with a mass fraction of 20%. The two solutions were mixed at a mass ratio of 3:2 to obtain a spinning solution.
将溶液通过以下参数进行静电纺丝,供液装置供液速率10mL/h,喷丝头与收集装置间距离25cm,喷丝头处接高压25kV,收集装置处接高压-10kV。The solution is electrospun with the following parameters, the liquid supply device supply rate is 10mL/h, the distance between the spinneret and the collection device is 25cm, the spinneret is connected to a high voltage of 25kV, and the collection device is connected to a high voltage of -10kV.
将收集到的复合纤维产物干燥,浸没在水中,排尽纤维内的空气。The collected composite fiber product is dried, immersed in water, and the air in the fiber is exhausted.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210324742.4A CN114808179B (en) | 2022-03-30 | 2022-03-30 | Composite material with controllable relaxation time and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210324742.4A CN114808179B (en) | 2022-03-30 | 2022-03-30 | Composite material with controllable relaxation time and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114808179A CN114808179A (en) | 2022-07-29 |
CN114808179B true CN114808179B (en) | 2023-06-16 |
Family
ID=82532391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210324742.4A Active CN114808179B (en) | 2022-03-30 | 2022-03-30 | Composite material with controllable relaxation time and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114808179B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116590806B (en) * | 2023-04-12 | 2024-07-19 | 华南理工大学 | Binary fatty acid eutectic composite fiber capable of magnetic resonance imaging and preparation and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH668555A5 (en) * | 1986-02-17 | 1989-01-13 | Schweizerische Viscose | X=ray contrast polyester filament contg. X=ray contrast agent - pref. polyethylene contg. bismuth oxide, prodn. and use, esp. for suture yarn |
US5558857A (en) * | 1991-06-03 | 1996-09-24 | Nycomed Imaging As | Contrast agents |
CN104562438A (en) * | 2013-10-17 | 2015-04-29 | 中国科学院理化技术研究所 | Gelatin-based micro-nano fiber membrane material and preparation method and application thereof |
CN106943606A (en) * | 2017-03-15 | 2017-07-14 | 贵州灿石正科信息咨询服务有限公司 | A kind of acoustic contrast agent |
-
2022
- 2022-03-30 CN CN202210324742.4A patent/CN114808179B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH668555A5 (en) * | 1986-02-17 | 1989-01-13 | Schweizerische Viscose | X=ray contrast polyester filament contg. X=ray contrast agent - pref. polyethylene contg. bismuth oxide, prodn. and use, esp. for suture yarn |
US5558857A (en) * | 1991-06-03 | 1996-09-24 | Nycomed Imaging As | Contrast agents |
CN104562438A (en) * | 2013-10-17 | 2015-04-29 | 中国科学院理化技术研究所 | Gelatin-based micro-nano fiber membrane material and preparation method and application thereof |
CN106943606A (en) * | 2017-03-15 | 2017-07-14 | 贵州灿石正科信息咨询服务有限公司 | A kind of acoustic contrast agent |
Non-Patent Citations (1)
Title |
---|
驰豫时间对电纺射流形成及纳米纤维形貌的影响;漆东岳;刘延波;陈威亚;肖友华;;高分子通报(12);第52-59页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114808179A (en) | 2022-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Uppal et al. | Hyaluronic acid nanofiber wound dressing—production, characterization, and in vivo behavior | |
CN105012991B (en) | Antibacterial anti hemorrhagic material with non-woven fibrous fabric structure and preparation method thereof | |
Liu et al. | Novel magnetic silk fibroin scaffolds with delayed degradation for potential long-distance vascular repair | |
US8460692B2 (en) | Alginate-based nanofibers and related scaffolds | |
Kolan et al. | Solvent based 3D printing of biopolymer/bioactive glass composite and hydrogel for tissue engineering applications | |
Fan et al. | Regenerated silk fibroin nanofibrous matrices treated with 75% ethanol vapor for tissue-engineering applications | |
Chen et al. | Synthesis and assessment of sodium alginate-modified silk fibroin microspheres as potential hepatic arterial embolization agent | |
CN114808179B (en) | Composite material with controllable relaxation time and preparation method and application thereof | |
CN102049066A (en) | Magnetic composite material and application thereof in regeneration and repair of bone tissues | |
CN105339485A (en) | Three-dimensional structures for cell or tissue culture | |
Zhou et al. | Axon mimicking hydrophilic hollow polycaprolactone microfibres for diffusion magnetic resonance imaging | |
CN110755684A (en) | Microsphere/nano yarn composite scaffold loaded with exosome and growth factor and preparation method thereof | |
Moradipour et al. | Core-shell nanofibers based on polycaprolactone/polyvinyl alcohol and polycaprolactone/collagen for biomedical applications | |
Feng et al. | Electrospun nanofibers with core–shell structure for treatment of bladder regeneration | |
Zhou et al. | Co-electrospraying of tumour cell mimicking hollow polymeric microspheres for diffusion magnetic resonance imaging | |
Kennell et al. | Fish skin gelatin nanofibrous scaffolds spun using alternating field electrospinning and in-vitro tested with tdTomato mice fibroblasts | |
CN109999222B (en) | Preparation method of nerve conduit material based on polyhydroxyalkanoate/sodium alginate electrospun nanofibers | |
Narayanan et al. | Correlation of the stoichiometries of poly (ε-caprolactone) and α-cyclodextrin pseudorotaxanes with their solution rheology and the molecular orientation, crystallite size, and thermomechanical properties of their nanofibers | |
Rez et al. | Tubular poly (ε-caprolactone)/chitosan nanofibrous scaffold prepared by electrospinning for vascular tissue engineering applications | |
CN114796531B (en) | A non-metallic temperature-responsive magnetic resonance imaging composite material and its preparation method and application | |
CN106620894B (en) | In-vivo implantation material capable of nuclear magnetic resonance imaging and preparation method and application thereof | |
Nergis et al. | The effect of polymer concentration on coaxial electrospinning of PVP/PCL core-sheath nanofibers | |
CN103469347A (en) | Preparation method of aliphatic polyester nanofiber with neutral pH after degradation | |
Zhou et al. | Coaxial electrospun biomimetic copolymer fibres for application in diffusion magnetic resonance imaging | |
Sivan et al. | Materials Today Chemistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |